Jolimark Holdings Limited (Stock Code: 02028) announced a profit warning for the financial year ended 31 December 2025, projecting an unaudited consolidated net loss of approximately RMB48.00 million to RMB55.00 million. This compares with a loss of RMB60.26 million recorded in FY2024, indicating a year-on-year reduction in negative earnings.
The Board attributed the anticipated loss mainly to: 1. Continued decline in printer market demand amid growing adoption of electronic invoicing. 2. Initial promotional expenses and limited revenue contribution from its medical equipment products, currently in the early market-entry phase. 3. Provisions for asset impairment.
Management emphasised that the figures are derived from preliminary, unaudited management accounts and may differ from the final audited results, which are scheduled for release before end-March 2026.
Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.